loader image
Monday, October 6, 2025
76.5 F
McAllen
- Advertisement -

Update on UT Health RGV COVID-19 vaccine efforts

Translate to Spanish or other 102 languages!

Image for illustration purposes only

Mega Doctor News

- Advertisement -

By UTRGV News & Internal Communications

RIO GRANDE VALLEY, TEXAS – Based on guidance recently obtained from State of Texas officials, UT Health RGV will no longer have to verify the residency of eligible patients who have registered to receive the COVID-19 vaccine from UT Health RGV. 

UT Health RGV already has administered more than 20,000 doses of the vaccine since December, and the new guidelines will make it easier for UT Health RGV to vaccinate more members of the Valley community. 

- Advertisement -

Anyone who already has registered with UT Health RGV to receive the vaccine but has been turned away because of their current residency should email covidvaccine@utrgv.edu to be rescheduled for the shots. 

NOTE: UT Health RGV’s vaccination registration remains temporarily closed to new registrants, until it can serve the more than 55,000 individuals who initially registered.  

UT Health RGV will reopen registration once the current registrants have been served and once the supply of vaccines provided by the State of Texas meets the current demand. 

For more information, visit the UT Health RGV vaccination webpage.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Breast Cancer Symposium, Oct. 11th 

To support providers in the community, the DHR Health Continuing Medical Education Department will host the Breast Cancer Symposium on Saturday, October 11, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado.

STHS Children’s to Host Monster Jam Patient Meet & Greet, Oct. 9th

On Thursday, October 9, 2025, from 2:00 – 4:00 p.m., the pediatric patients at South Texas Health System Children’s will have the opportunity to experience monster truck magic without leaving the hospital grounds.

Why Lobular Breast Cancer Can be Difficult to Detect

Reports show that one in eight women will be diagnosed with breast cancer in their lifetime. 

DHR Health Introduces Advanced PSMA-PET Imaging with Illuccix® for Prostate Cancer Care

To support early and accurate detection, DHR Health now offers Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection), a prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging tracer for the detection of prostate cancer.
- Advertisement -
×